Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies
Abstract The δ-opioid receptor (DOP) is an attractive pharmacological target due to its potent analgesic, anxiolytic and anti-depressant activity in chronic pain models. However, some but not all selective DOP agonists also produce severe adverse effects such as seizures. Thus, the development of no...
Guardado en:
Autores principales: | Anika Mann, Sophia Liebetrau, Marie Klima, Pooja Dasgupta, Dominique Massotte, Stefan Schulz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a9660019a0841789184816179841e8c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D2 receptor regulation and signaling
por: Anika Mann, et al.
Publicado: (2021) -
Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists
por: Parthasaradhireddy Tanguturi, et al.
Publicado: (2021) -
The expression of delta opioid receptor mRNA in adult male zebra finches (Taenopygia guttata).
por: Pooja Parishar, et al.
Publicado: (2021) -
Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases?
por: Patrycja Redkiewicz, et al.
Publicado: (2021) -
Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects
por: A. Kliewer, et al.
Publicado: (2019)